Ascendis Pharma A/S (ASND) vs Insmed, Inc. (INSM)

• Ascendis Pharma A/S ASND 257.82 ▲ +1.72%
• Insmed, Inc. INSM 111.96 ▲ +2.94%

Ascendis Pharma A/S and Insmed, Inc. are both Biotechnology companies. Insmed, Inc. is the larger, with a market value of $23.9B against $16.6B — 1.4× the size. Insmed, Inc. has negative trailing earnings, so its P/E is not meaningful; Ascendis Pharma A/S trades at 18.3×. Insmed, Inc. grew revenue faster over the last twelve months: 240.0% against 126.0%. Ascendis Pharma A/S has the higher net margin (71.2% vs −39.9%) and the higher return on invested capital (15.1% vs −247.6%). Across the 18 metrics below, Ascendis Pharma A/S leads on 17 and Insmed, Inc. on 1.